Melbourne, Victoria, Australia
Senior business development and licensing leader with over a decade’ experience, I operate at the intersection of science, strategy, and value creation in the global life sciences sector. With a PhD, MBA, and governance training (AICD), I bring strong scientific literacy, commercial judgment, and enterprise perspective to complex partnering, licensing, and diligence decisions. I have led and executed global BD transactions, chaired cross‑functional deal teams, supported portfolio and TA strategy, and contributed to the evaluation of a broad pipeline of external opportunities. Known for clarity of thinking, integrity, and execution discipline, I partner closely with Research and Development, Legal, Finance, and senior leadership to translate complexity into decisions that create long‑term value.
Operating at the intersection of sector-led commercialisation and enterprise capability build, the role is accountable for advancing high-quality commercialisation opportunities and partnerships, including contributing to the development, prioritisation, and progression of the Life Sciences pipeline. In parallel, I lead the design and delivery of a modern, scalable partnership and deal management platform, enabling clear visibility and active management of pipeline, partnerships, and commercial outcomes.
• Established a small family business in a highly regulated industry – French immersive day care centre for children aged 2 to 5 years old. • Responsible for regulatory compliance, HR and accounting.
• Supported and executed strategic business development and licensing initiatives aligned with organizational vision and long‑term strategy. • Identified, assessed, and prioritized partnership opportunities within Hematology. • Led and coordinated cross‑functional teams to conduct scientific, commercial, and legal due diligence, and through the full transaction lifecycle • Provided strategic input to opportunity evaluation, partner selection, and transaction structuring.
• Supported global licensing activities across multiple therapeutic areas (immunology, hematology, vaccines, product development). • Negotiated and executed a broad range of commercial agreements, including licenses, collaborations, and strategic partnerships. • Led deal teams through end‑to‑end transaction processes • Conducted and coordinated due diligence activities to support informed investment and partnering decisions.
• Partnered with the School of Clinical Sciences at Monash Health and the Victorian Heart Institute to support research engagement and development. • Identified commercial opportunities and potential industry partners for academic research programs. • Led commercial and contractual negotiations with external partners. • Acted as a key liaison between researchers, institutional stakeholders, and industry.
• Managed a portfolio of commercial projects, including spin‑out company formation and growth. • Led contracting activities and the identification and assessment of new intellectual property. • Engaged extensively with internal and external stakeholders across research, legal, and investment functions. • Managed the Institute’s internal Innovation Fund. • Supported governance of multiple spin‑out companies, including Cardiora, Kinomedica, Limulus Therapeutics, and Oxydend Therapeutics.
• Conducted medical research across a range of projects, in cardiovascular and metabolic diseases. • Contributed to experimental design, data analysis, and scientific reporting.